Real-World Data from a Multi-Center Study: Insights to Psoriatic Arthritis Care

Real-World Data from a Multi-Center Study: Insights to Psoriatic Arthritis Care

Introduction: Real-world data indicate disparities in biologic access across Europe. Objectives: To describe the national structure of PsA care in Poland, with a particular focus on the population of inadequate responders (IRs) and difficulties associated with biologic therapy access. Methods: A poo...

Full description

Bibliographic Details
Main Authors:	Bogdan Batko, Eugeniusz Kucharz, Marcin Stajszczyk, Marek Brzosko, Włodzimierz Samborski, Zbigniew Żuber
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Series:	Journal of Clinical Medicine
Subjects:	treat-to-target psoriatic arthritis barriers real world difficult-to-treat
Online Access:	https://www.mdpi.com/2077-0383/10/18/4106

Similar Items

Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
by: Ennio Lubrano, et al.
Published: (2023-07-01)

TREAT-TO-TARGET STRATEGY FOR EARLY PSORIATIC ARTHRITIS (PRELIMINARY RESULTS OF THE REMARCА STUDY)
by: T. V. Korotaeva, et al.
Published: (2016-12-01)

TREAT-TO-TARGET STRATEGY FOR EARLY PSORIATIC ARTHRITIS (PRELIMINARY RESULTS OF THE REMARCА STUDY)
by: T. V. Korotaeva, et al.
Published: (2014-09-01)

Psoriatic arthritis treatment to the target: a consensus, evidence-based clinical practice recommendations for the management of psoriatic arthritis and its concomitant clinical manifestations
by: Yasser El Miedany, et al.
Published: (2022-06-01)

Difficult-to-treat rheumatoid arthritis in real clinical practice. Preliminary results
by: Elena A. Galushko, et al.
Published: (2022-06-01)

Psoriatic arthritis: pathogenetic features and innovative therapies
by: A. M. Lila, et al.
Published: (2019-01-01)

Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
by: Ju-Yang Jung, et al.
Published: (2023-09-01)

2-years outcomes of the treat-to-target strategy in early psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2022-11-01)

Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
by: Philip J. Mease, et al.
Published: (2023-08-01)

Non-pharmacological treatment in difficult-to-treat rheumatoid arthritis
by: Judit Majnik, et al.
Published: (2022-08-01)

Prognostic factors associated with achieving minimal disease activity in early psoriatic arthritis patients treated according to “treat-to-target” st rategy within 12 months
by: E. Yu. Loginova, et al.
Published: (2022-12-01)

Ten years of follow-up data in psoriatic arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway
by: Glenn Haugeberg, et al.
Published: (2018-08-01)

ACHIEVEMENT OF MINIMAL DISEASE ACTIVITY AND PROGRESSION OF RADIOGRAPHIC CHANGES IN EARLY PSORIATIC ARTHRITIS ONE YEAR AFTER INITIATION OF TREATMENT IN «TREAT TO TARGET» STRATEGY (PRELIMINARY RESULTS OF THE REMARKA STUDY)
by: E. Yu. Loginova, et al.
Published: (2018-01-01)

«TREAT-TO-TARGET» (T2T) STRATEGY IN SPONDYLOARTHRITIS
by: Sh. F. Erdes
Published: (2014-06-01)

IS PSORIATIC ARTHRITIS REALLY PSORIATIC?
by: Sh. F. Erdes
Published: (2014-12-01)

Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis—study protocol for the MONITOR-PsA study, a trials within cohorts study design
by: Ines Rombach, et al.
Published: (2021-03-01)

Effectiveness of a treat-to-target strategy in patients with moderate to severely active rheumatoid arthritis treated with abatacept
by: Louis Bessette, et al.
Published: (2023-09-01)

Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritis
by: Juan José Alegre-Sancho, et al.
Published: (2023-11-01)

Exploring the Diverse Immune and Genetic Landscape of Psoriatic Arthritis
by: Bogdan Batko
Published: (2021-12-01)

Nail disease in psoriatic arthritis. Data from the Russian Psoriatic Arthritis Registry
by: E. E. Gubar, et al.
Published: (2021-10-01)

Psoriatic erythroderma: comparative patient profile and association with psoriatic arthritis
by: Elena V. Bogdanova
Published: (2023-01-01)

Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study
by: Beatriz Joven, et al.
Published: (2023-07-01)

Use of Topical Nitric–Zinc Complex Solution to Treat Palmoplantar and Periungual Warts in a Pediatric Population
by: Aniza Giacaman, et al.
Published: (2019-10-01)

The identification, goals and principles of difficult-to-treat inflammatory arthritis: a consensus statement
by: Yasser El Miedany, et al.
Published: (2023-11-01)

The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes
by: Gabriele De Marco, et al.
Published: (2017-07-01)

Use of a multidimensional RAPID3 questionnaire to assess the achievement of remission and minimal disease activity in patients with early psoriatic arthritis treated according to Treat-to-target strategy
by: E. Yu. Loginova, et al.
Published: (2019-01-01)

MANAGEMENT OF PSORIATIC ARTHRITIS IN CHILDREN
by: Alina Murgu, et al.
Published: (2016-06-01)

Real-world evidence for ixekizumab in the treatment of psoriasis and psoriatic arthritis: literature review 2016–2021
by: Adam Reich, et al.
Published: (2023-12-01)

Psoriatic arthritis: imaging techniques
by: E. Lubrano, et al.
Published: (2012-06-01)

ENTHESITIS AND PSORIATIC ONYCHOPATHY AS A FACTOR FOR PREDICTION OF PSORIATIC ARTHRITIS IN PSORIASIS
by: Tatyana G. Sidorcika, et al.
Published: (2018-04-01)

Patient-Centered Care in Psoriatic Arthritis—A Perspective on Inflammation, Disease Activity, and Psychosocial Factors
by: Bogdan Batko
Published: (2020-09-01)

Clinical profiling of psoriatic arthritis: an observational cross-sectional study from Karnataka Psoriatic Arthritis Cohort
by: Chanakya Kodishala, et al.
Published: (2022-01-01)

Methotrexate in a psoriatic arthritis patient
by: K. V. Aleksanyan, et al.
Published: (2022-12-01)

Targeted Therapies in Axial Psoriatic Arthritis
by: Alberto Floris, et al.
Published: (2021-06-01)

Enthesitis in psoriatic arthritis
by: Mihaela Agache, et al.
Published: (2021-09-01)

Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness
by: Alin Codrut Nicolescu, et al.
Published: (2022-12-01)

Radiographic progression can still occur in individual patients with low or moderate disease activity in the current treat-to-target paradigm: real-world data from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry
by: Peter M. ten Klooster, et al.
Published: (2019-11-01)

Real-world evidence of biologic treatments in psoriatic arthritis in Italy: results of the CHRONOS (EffeCtiveness of biologic treatments for psoriatic artHRitis in Italy: an ObservatioNal lOngitudinal Study of real-life clinical practice) observational longitudinal study
by: Delia Colombo, et al.
Published: (2022-09-01)

Comorbidities in Patients with Psoriatic Arthritis
by: Amir Haddad, et al.
Published: (2017-01-01)

Biomarkers in psoriatic arthritis: A meta-analysis and systematic review
by: Theo Wirth, et al.
Published: (2022-11-01)